Kendall Capital Management acquired a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 19,682 shares of the company’s stock, valued at approximately $2,529,000.
A number of other institutional investors also recently bought and sold shares of MKGAF. Frazier Financial Advisors LLC acquired a new position in Merck KGaA in the 2nd quarter valued at about $25,000. Rakuten Securities Inc. acquired a new stake in shares of Merck KGaA during the 2nd quarter worth approximately $27,000. Bard Associates Inc. purchased a new stake in shares of Merck KGaA during the 2nd quarter valued at approximately $60,000. Kilter Group LLC purchased a new stake in shares of Merck KGaA during the 2nd quarter valued at approximately $62,000. Finally, Addison Advisors LLC acquired a new position in Merck KGaA in the second quarter valued at approximately $90,000. 0.10% of the stock is owned by hedge funds and other institutional investors.
Merck KGaA Trading Up 0.7%
Shares of Merck KGaA stock opened at $163.21 on Friday. The stock has a 50 day moving average of $162.62 and a 200 day moving average of $148.46. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The firm has a market capitalization of $21.09 billion, a price-to-earnings ratio of 24.92 and a beta of 0.96. Merck KGaA has a fifty-two week low of $116.68 and a fifty-two week high of $175.56.
About Merck KGaA
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Articles
- Five stocks we like better than Merck KGaA
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
